1 completed, 1 unknown. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow HLB Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration C-Trelin OD Tab(5mg Taltirelin Hydrate), Placebo - Spinocerebellar Degeneration | Phase 4 | Completed | HLB Pharmaceutical Co., Ltd. | 160 | 2019-03-04 | 2023-07-24 |
| Phase 1 Single Dose Escalation Study of CTB-001 CTB-001 - Healthy | Phase 1 | Unknown | HLB Pharmaceutical Co., Ltd. | 33 | 2012-07-01 | 2012-07-24 |
Ataxia (1) · Spinocerebellar Degenerations (1)
TA 0910 (1) · bivalirudin (1)
South Korea (2)
Kyun-Seop Bae, M.D., Ph.D. (1) · Seong-beom Koh (1)